1. Home
  2. RCUS vs AMRC Comparison

RCUS vs AMRC Comparison

Compare RCUS & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • AMRC
  • Stock Information
  • Founded
  • RCUS 2015
  • AMRC 2000
  • Country
  • RCUS United States
  • AMRC United States
  • Employees
  • RCUS N/A
  • AMRC N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • AMRC Engineering & Construction
  • Sector
  • RCUS Health Care
  • AMRC Consumer Discretionary
  • Exchange
  • RCUS Nasdaq
  • AMRC Nasdaq
  • Market Cap
  • RCUS 1.4B
  • AMRC 1.5B
  • IPO Year
  • RCUS 2018
  • AMRC 2010
  • Fundamental
  • Price
  • RCUS $14.15
  • AMRC $24.21
  • Analyst Decision
  • RCUS Buy
  • AMRC Strong Buy
  • Analyst Count
  • RCUS 12
  • AMRC 10
  • Target Price
  • RCUS $34.50
  • AMRC $36.88
  • AVG Volume (30 Days)
  • RCUS 583.4K
  • AMRC 409.3K
  • Earning Date
  • RCUS 02-19-2025
  • AMRC 02-27-2025
  • Dividend Yield
  • RCUS N/A
  • AMRC N/A
  • EPS Growth
  • RCUS N/A
  • AMRC 13.70
  • EPS
  • RCUS N/A
  • AMRC 1.00
  • Revenue
  • RCUS $263,000,000.00
  • AMRC $1,678,629,000.00
  • Revenue This Year
  • RCUS $127.65
  • AMRC $30.73
  • Revenue Next Year
  • RCUS N/A
  • AMRC $11.19
  • P/E Ratio
  • RCUS N/A
  • AMRC $23.77
  • Revenue Growth
  • RCUS 119.17
  • AMRC 32.70
  • 52 Week Low
  • RCUS $13.51
  • AMRC $17.55
  • 52 Week High
  • RCUS $20.31
  • AMRC $39.68
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 39.00
  • AMRC 46.18
  • Support Level
  • RCUS $13.81
  • AMRC $22.56
  • Resistance Level
  • RCUS $14.45
  • AMRC $25.30
  • Average True Range (ATR)
  • RCUS 0.57
  • AMRC 1.47
  • MACD
  • RCUS -0.06
  • AMRC -0.05
  • Stochastic Oscillator
  • RCUS 30.40
  • AMRC 27.53

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of revenue from the U.S. Regions segment.

Share on Social Networks: